Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Open accessThe DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Abstract
Paget disease of bone (PDB) is a common disorder characterized by focal and disorganized increases of bone turnover. Genetic factors are important in the pathogenesis of PDB. We and others recently mapped the third locus associated with the disorder, PDB3, at 5q35-qter. In the present study, by use of 24 French Canadian families and 112 unrelated subjects with PDB, the PDB3 locus was confined to approximately 300 kb. Within this interval, two disease-related haplotype signatures were observed in 11 families and 18 unrelated patients. This region encoded the ubiquitin-binding protein sequestosome 1 (SQSTM1/p62), which is a candidate gene for PDB because of its association with the NF-kappaB pathway. Screening SQSTM1/p62 for mutations led to the identification of a recurrent nonconservative change (P392L) flanking the ubiquitin-associated domain (UBA) (position 394-440) of the protein that was not present in 291 control individuals. Our data demonstrate that two independent mutational events at the same position in SQSTM1/p62 caused PDB in a high proportion of French Canadian patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [403]
In the citing paper
“SQSTM1 mutations are not only a rare cause of ALS-FTD, accounting for ~1-3.5% of cases with or without family history [123–125], but also Paget’s disease of bone (PDB), a chronic and progressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [126]
Citations
Cites
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599 · cited 4×
“Cosegregation of the P392L variant with the phenotype, its absence in 86 spouses and 205 individuals from the general population, the nonconservative nature of the amino acid substitution, and the conservation of the UBA domain, including the P392 residue, among other species (mouse and rat) provided support for the i…”
BackgroundInfluentialA comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928 · cited 1×
“markers (Dib et al. 1996), present within this interval, using an ePCR approach (Schuler 1998).”
MethodSelf-citationHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“Osteoclast formation and activation involve the receptor activator of NF-kB (RANK) pathway, a tumor-necrosis factor (TNF) family member (Hsu et al. 1999).”
BackgroundThe staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263 · cited 1×
“Both strands were analyzed using STADEN package 1.1 (Staden 1996).”
MethodInfluentialSobel, E. M., & Lange, K. L. (1996) · PubMed Central · Cited by 1,176
Principles and Practice of Endocrinology and Metabolism.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-816_4 · Cited by 803
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635 · cited 6×
“1999), and TRAF6-deficient mice exhibit severe osteopetrosis and are defective in osteoclast formation because of impaired signaling induced by RANK (Naito et al. 1999).”
BackgroundInfluentialMutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., MacPherson, H., Wallace, R. G. H., van Hul, W., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481 · cited 1×
“Activating mutations of the TNFRSF11A gene encoding this receptor have been found to be responsible for FEO and rare cases of early-onset familial PDB (Hughes et al. 2000).”
BackgroundThe atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluentialThe interaction of p62 with RIP links the atypical PKCs to NF-kappa B activation
Sanz, L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluential
Research works printed but not linked: 1
- Glaser, 1999, Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism, Hum Mutat, 14, 23, 10.1002/(SICI)1098-1004(1999)14:1<23::AID-HUMU3>3.0.CO;2-# · doi:10.1002/(sici)1098-1004(1999)14:1<23::aid-humu3>3.0.co;2-#
Cited by
Items 101–200 of 563
Paget?s Disease of Bone in New Zealand: Continued Decline in Disease Severity
Cundy, H., Gamble, G. D., Wattie, D. J., Rutland, M. D., & Cundy, T. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0281-z · Cited by 110
Ca2+in quality control: An unresolved riddle critical to autophagy and mitophagy
East, D. A., & Campanella, M. (2013) · Autophagy · doi:10.4161/auto.25367 · Cited by 107
“Aberrant SQSTM1 expression is associated with several disease states; an upregulation is observed both in Parkinson and Huntington disease,(41,42) whereas reduced expression is linked to Alzheimer disease and Paget disease of bone.(43,44,53) Finally, in a separate study, rapid elevation in [Ca] C induced by extracellu…”
BackgroundKurihara, N., Zhou, H., Reddy, S. V., Palacios, V. G., Subler, M. A., Dempster, D. W., Windle, J. J., & Roodman, G. D. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051108 · Cited by 104
“The abnormally thickened and coarse trabeculae were remarkably similar to those seen in PD, and the fact that these dramatic lesions were only observed in the oldest animals is also consistent with the slow development of pagetic lesions.”
BackgroundInfluentialPathogenesis of Paget's disease of bone
Ralston, S. H. (2008) · Bone · doi:10.1016/j.bone.2008.06.015 · Cited by 126
“The frequency of SQSTM1 mediated Paget's disease differs in different populations, but it appears that between 10–50% of patients with familial PDB and between 5–30% of patients with “sporadic” PDB carry mutations in SQSTM1 [13,21,35,52,93].”
BackgroundEekhoff, E. W. M., Karperien, M., Houtsma, D., Zwinderman, A. H., Dragoiescu, C., Kneppers, A. L. J., & Papapoulos, S. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20224 · Cited by 103
Targeted next-generation sequencing assay for detection of mutations in primary myopathies
Evilä, A., Arumilli, M., Udd, B., & Hackman, P. (2015) · Neuromuscular Disorders · doi:10.1016/j.nmd.2015.10.003 · Cited by 106
ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function
Baron, D. M., Fenton, A. R., Saez-Atienzar, S., Giampetruzzi, A., Sreeram, A., Shankaracharya, Keagle, P. J., Doocy, V. R., Smith, N. J., Danielson, E. W., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110598 · Cited by 101
Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts
Aono, J., Yanagawa, T., Itoh, K., Li, B., Yoshida, H., Kumagai, Y., Yamamoto, M. P., & Ishii, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00728-9 · Cited by 103
Gennari, L., Rendina, D., Falchetti, A., & Merlotti, D. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00522-3 · Cited by 109
Wu, B.-T., Su, Y.-H., Tsai, M.-T., Wasserman, S. M., Topper, J. N., & Yang, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405912200 · Cited by 101
Orange, J. S., Levy, O., & Geha, R. S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00221.x · Cited by 103
“Finally, mutations in the SQSTM1 gene encoding sequestosome 1 (also known as p62) result in increased osteoclast function and the typical form of Paget’s disease, which becomes apparent later in life (42, 43).”
BackgroundCellular functions of optineurin in health and disease
Slowicka, K., Vereecke, L., & van Loo, G. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.07.002 · Cited by 96
Paget’s disease of bone and genetic disorders of RANKL/OPG/RANK/NF-κB signaling.
WHYTE, M. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.016 · Cited by 95
Kim, J. Y., & Ozato, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802755 · Cited by 107
“Mutations of p62 are associated with bone diseases (32, 33).”
BackgroundThe role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma
Ehrlich, L. A., & Roodman, G. D. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00323.x · Cited by 100
“(29) reported a point mutation (P392L) in SQSTM1, which maps to chromosome 5q35, in two French Canadian Paget’s families and several unrelated”
BackgroundHelfrich, M. H. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10375 · Cited by 93
“Having first found linkage of PDB to chromosome 5q in a number of French Canadian families, Laurin and co-workers recently described a non-conservative heterozygous point mutation in a novel gene, SQSTM1 (sequestosome1) in 11% of families and 16% of sporadic cases (Laurin et al., 2002).”
BackgroundRea, S. L., Walsh, J. P., Ward, L., Yip, K., Ward, B. K., Kent, G. N., Steer, J. H., Xu, J., & Ratajczak, T. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060405 · Cited by 93
“Exon 8 was amplified by PCR using forward and reverse primers described previously((10)): CACTgTggCCTgTgAggAC and CAgTgAgCCTTgggTCTCg, respectively.”
MethodLattante, S., de Calbiac, H., Le Ber, I., Brice, A., Ciura, S., & Kabashi, E. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu580 · Cited by 90
Genotype-phenotype correlations of amyotrophic lateral sclerosis
Li, H.-F., & Wu, Z.-Y. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0050-8 · Cited by 91
“AAO: age at onset; AD: Alzheimer’s disease; ALS: amyotrophic lateral sclerosis; ANG: angiogenin; AOA2: oculomotor apraxia type 2; ATXN2: ataxin-2; C9ORF72: chromosome 9 open reading frame 72; CMT4J: Charcot-MarieTooth disease; DCTN1: dynactin; ERBB4: erb-b2 receptor tyrosine kinase 4; FALS: familial amyotrophic latera…”
BackgroundHiruma, Y., Kurihara, N., Subler, M. A., Zhou, H., Boykin, C. S., Zhang, H., Ishizuka, S., Dempster, D. W., Roodman, G. D., & Windle, J. J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn266 · Cited by 90
“However, mutations in only one of these genes, SQSTM1/p62, are generally associated with classical PDB (9,10), and up to 30% of familial PDB patients and 10% of sporadic patients have a p62 mutation (11–13).”
BackgroundBone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysis
Nofal, A. A., Altayar, O., Benkhadra, K., Agha, O. Q., Asi, N., Nabhan, M., Prokop, L. J., Tebben, P. J., & Murad, M. H. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3095-0 · Cited by 103
“Studies have shown that a high proportion of patients with familial cases of Paget’s disease have mutations in the sequestosome 1 (SQSTM1) gene [6, 7].”
BackgroundOsteoclast diseases and dental abnormalities
Helfrich, M. (2005) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2004.11.016 · Cited by 96
Tissue specificity in the nuclear envelope supports its functional complexity
Heras, J. I. D. L., Meinke, P., Batrakou, D. G., Sršeň, V., Zuleger, N., Kerr, A. R. W., & Schirmer, E. C. (2013) · Nucleus · doi:10.4161/nucl.26872 · Cited by 95
Falchetti, A., Di Stefano, M., Marini, F., Del Monte, F., Mavilia, C., Strigoli, D., De Feo, M. L., Isaia, G., Masi, L., Amedei, A., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040203 · Cited by 87
“As for the originally reported exon 8 P392L mutation,((16,18)) the two novel mutations observed in Italian PBD patients, M404V and G425R, consist of a conservative and a nonconservative amino acid substitution at residues M and G, respectively; both are conserved across species.”
BackgroundInfluentialZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor
Divisato, G., Formicola, D., Esposito, T., Merlotti, D., Pazzaglia, L., Del Fattore, A., Siris, E., Orcel, P., Brown, J. P., Nuti, R., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.12.016 · Cited by 85
“8,9 Genome-wide association studies have suggested additional predisposition loci in individuals with PDB who are negative for SQSTM1 mutations.”
Self-citationBlauwendraat, C., Wilke, C., Simón‐Sánchez, J., Jansen, I. E., Reifschneider, A., Capell, A., Haass, C., Castillo-Lizardo, M., Biskup, S., Maetzler, W., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.102 · Cited by 91
Paget’s disease of bone: a review of epidemiology, pathophysiology and management
Shaker, J. L. (2009) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x09351779 · Cited by 93
“Evaluation of patients with PDB3 (chromosome 5q35) mutations resulted in the discovery that the sequestosome 1 (SQSTM1) mutations are an important cause of PDB [Laurin et al. 2002; Hocking et al. 2002].”
BackgroundMutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone
Visconti, M. R., Langston, A. L., Alonso, N., Goodman, K., Selby, P. L., Fraser, W. D., & Ralston, S. H. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.132 · Cited by 90
“The most important of these is SQSTM1, which was identified initially in patients with familial PDB by positional cloning.((11)) Subsequent studies showed that SQSTM1 mutations occur in up to 40% of patients with a familial PDB and up to 10% of patients with ‘‘sporadic’’ PDB.”
BackgroundDelayed Development of Paget's Disease in Offspring Inheriting SQSTM1 Mutations
Bolland, M. J., Tong, P. C., Naot, D., Callon, K. E., Wattie, D. J., Gamble, G. D., & Cundy, T. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061204 · Cited by 83
“SQSTM1 mutations are thought to be highly penetrant((4,7)) and are rare in people without Paget’s disease.”
BackgroundInfluentialWhitehouse, C. A., Waters, S., Marchbank, K., Horner, A., McGowan, N. W. A., Jovanovic, J. V., Xavier, G. M., Kashima, T. G., Cobourne, M. T., Richards, G. O., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913058107 · Cited by 82
“Mutations of p62 are found in sporadic and 5q35linked familial cases of Paget’s disease of bone (PDB) (13, 14), which is characterized by increased osteoclast and osteoblast activity leading to the formation of an excess of poorly structured bone that is liable to fracture (15, 16).”
BackgroundInfluentialSeton, M., Choi, H. K., Hansen, M. F., Sebaldt, R. J., & Cooper, C. C. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.8.1519 · Cited by 86
“England/Ireland 17 (6) 4 (5) 38 (13) 12 (16) 44 (15) 13 (17)”
BackgroundAdult Paget’s disease of bone: a review
Tuck, S. P., Layfield, R., Walker, J., Mekkayil, B., & Francis, R. M. (2016) · Rheumatology · doi:10.1093/rheumatology/kew430 · Cited by 91
Moscat, J., Diaz-Meco, M. T., & Wooten, M. W. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.119 · Cited by 81
“from the discovery that it harbors several mutations associated with Paget’s disease of the bone (PDB).(92,93) This suggested that a major role for p62 in humans was likely to be linked to the control of bone homeostasis.”
BackgroundMotor neuron disease and frontotemporal dementia: sometimes related, sometimes not
Hardy, J., & Rogaeva, E. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.006 · Cited by 94
“Similar to VCP, the heterozygousmissense or nonsensemutations in the SQSTM1 gene cause PDB (MIM: 602080) (Laurin et al., 2002).”
Novel ALK fusion partners in lung cancer
Iyevleva, A. G., Раскин, Г. А., Tiurin, V. I., Соколенко, А. П., Mitiushkina, N. V., Алексахина, С. Н., Garifullina, A. R., Strelkova, T. N., Merkulov, V. O., Ivantsov, A. O., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.028 · Cited by 83
“SQSTM1 mutations are associated with Paget bone disease [31].”
BackgroundCollet, C., Michou, L., Audran, M., Chasseigneaux, S., Hilliquin, P., Bardin, T., Lemaire, I., Cornélis, F., Launay, J.-M., Orcel, P., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061106 · Cited by 78
SQSTM1 and Paget?s Disease of Bone
Layfield, R., & Hocking, L. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0041-0 · Cited by 76
“A recurrent C>T transition at position +1215 on the cDNA sequence of SQSTM1 (NM_003900), which results in a proline to leucine amino acid substitution at codon 392 (P392L), was the first to be identified [30].”
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone
Gennari, L., Gianfrancesco, F., Di Stefano, M., Rendina, D., Merlotti, D., Esposito, T., Gallone, S., Fusco, P., Rainero, I., Fenoglio, P., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.31 · Cited by 77
“In 2002, Laurin and colleagues identified a recurrent C!T transition at position þ1215 leading to a proline-to-leucine substitution at codon 392 (P392L) on the SQSTM1 gene (within the 5q35 PDB3 locus) as a cause of PDB in about 50% and 20% of familial and sporadic French-Canadian patients, respectively.((8)) This gene…”
BackgroundMethodResultInfluentialCundy, T. (2018) · Metabolism · doi:10.1016/j.metabol.2017.06.010 · Cited by 76
Cavey, J. R., Ralston, S. H., Sheppard, P. W., Ciani, B., Gallagher, T. R. A., Long, J., Searle, M. S., & Layfield, R. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-1299-6 · Cited by 82
Boudin, E., Fijałkowski, I., Hendrickx, G., & Hul, W. V. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.12.021 · Cited by 87
Yip, K. H. M., Feng, H., Pavlos, N. J., Zheng, M., & Xu, J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050960 · Cited by 80
The p62 P392L Mutation Linked to Paget’s Disease Induces Activation of Human Osteoclasts
Chamoux, E., Couture, J., Bisson, M., Morissette, J., Brown, J. P., & Roux, S. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0066 · Cited by 73
“Mutations in the gene encoding p62 have been shown to be involved in the pathogenesis of PDB (3).”
BackgroundMethodInfluentialSelf-citationCharacteristics and Familial Aggregation of Paget's Disease of Bone in Italy
Merlotti, D., Gennari, L., Galli, B., Martini, G., Calabrò, A. R., Paola, V. D., Ceccarelli, E., Nardi, P., Avanzati, A., & Nuti, R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050322 · Cited by 86
“(38) Possibly, different paramyxovirus infections may be responsible of PDB.”
BackgroundInfluentialMartini, G., Gennari, L., Merlotti, D., Salvadori, S., Franci, M. B., Campagna, S., Avanzati, A., De Paola, V., Valleggi, F., & Nuti, R. (2007) · Bone · doi:10.1016/j.bone.2006.08.003 · Cited by 72
“More recently, mutations in the sequestosome 1 gene, which is a scaffold protein in the NF-kB signaling pathway, have been described in between 20–50% of familial and 10– 20% of sporadic PDB cases [22–28].”
BackgroundPatergnani, S., Missiroli, S., Morciano, G., Perrone, M., Mantovani, C. M., Anania, G., Fiorica, F., Pinton, P., & Giorgi, C. (2021) · Cancers · doi:10.3390/cancers13225622 · Cited by 77
“Furthermore, mutations of p62/SQSTM1 have been linked to Paget’s disease too, a disorder of bone metabolism [103].”
BackgroundMolecular genetics of too much bone
Janssens, K. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2385 · Cited by 72
Paget's Disease of Bone in Italy
Gennari, L., Merlotti, D., Martini, G., & Nuti, R. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s203 · Cited by 73
“Interestingly, different infective agents may be involved in the pathogenesis of PDB. Typical paramyxoviruses that have been previously associated with PDB are canine distemper virus and measles virus.”
BackgroundResultInfluentialGenetics of Paget's disease of bone
Daroszewska, A., & Ralston, S. H. (2005) · Clinical Science · doi:10.1042/cs20050053 · Cited by 71
Deficiency of p62/Sequestosome 1 Causes Hyperphagia Due to Leptin Resistance in the Brain
Harada, H., Warabi, E., Matsuki, T., Yanagawa, T., Okada, K., Uwayama, J., Ikeda, A., Nakaso, K., Kirii, K., Noguchi, N., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2954-12.2013 · Cited by 68
“Of note, mutations in human SQSTM1 cause 5q35-linked Paget’s disease of the bone (Laurin et al., 2002); osteoclasts are hyperactivated in this disease.”
BackgroundPaget's disease of bone—genetic and environmental factors
Singer, F. R. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.138 · Cited by 78
Genetics and aetiology of Pagetic disorders of bone
Helfrich, M., & Hocking, L. J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.045 · Cited by 76
Daroszewska, A., Hocking, L. J., McGuigan, F. E., Langdahl, B. L., Stone, M. D., Cundy, T., Nicholson, G. C., Fraser, W. D., & Ralston, S. H. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040602 · Cited by 72
“Because we and others have previously shown that mutations of the SQSTM1 are an important cause of familial PDB,((19,20))”
BackgroundAlvarez, L., Peris, P., Guañabens, N., Vidal, S., Ros, I., Pons, F., Filella, X., Monegal, A., Muñoz‐Gomez, J., & Ballesta, A. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10834 · Cited by 66
Multisystem proteinopathy: Where myopathy and motor neuron disease converge
Korb, M. K., Kimonis, V. E., & Mozaffar, T. (2020) · Muscle & Nerve · doi:10.1002/mus.27097 · Cited by 71
Regulation of autophagy by Ca2+
Sun, F., Xu, X., Wang, X., & Zhang, B. (2016) · Tumor Biology · doi:10.1007/s13277-016-5353-y · Cited by 73
“In addition, LRRK2 overexpression upregulates the levels of SQSTM1/p62 in a Ca-dependent manner, which links ubiquitinated targets to the autophagic machinery [72].”
Ching, J. K., Elizabeth, S. V., Ju, J.-S., Lusk, C., Pittman, S. K., & Weihl, C. C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds524 · Cited by 64
Chang, K. H., Sengupta, A., Nayak, R. C., Durán, Á., Lee, S. J., Pratt, R. G., Wellendorf, A. M., Kargbo-Hill, S. E., Watkins, M. P., González‐Nieto, D., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.031 · Cited by 66
“, 2012) and in pathology as documented by the role of p62 mutations in Paget disease of the bone (Laurin et al., 2002; Rea et al., 2013).”
Paget's Disease of Bone: Evidence for Complex Pathogenetic Interactions
Chung, P. Y. J., & Hul, W. V. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.07.005 · Cited by 70
“The disease occurs rarely in other parts of the world (i.e. Africa, Middle East, and Asia) (11-23), unless after migration and integration of a risk population such as the massive British migration to Australia (3,24) and the French acquisition movement to North America (3,25,26).”
BackgroundInfluentialIdentification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees
Good, D. M., Busfield, F., Fletcher, B. H., Lovelock, P. K., Duffy, D. L., Kesting, J. B., Andersen, J., & Shaw, J. T. E. (2004) · Bone · doi:10.1016/j.bone.2004.01.010 · Cited by 66
Abdulrahman, B., Khweek, A. A., Akhter, A., Caution, K., Tazi, M., Hassan, H., Zhang, Y., Rowland, P. D., Malhotra, S., Aeffner, F., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.411728 · Cited by 69
“The adaptor molecule p62 is a ubiquitously expressed cellular protein that is conserved in metazoa but not in plants or fungi (15, 16).”
BackgroundOtomo, A., Pan, L., & Hadano, S. (2012) · Neurology Research International · doi:10.1155/2012/498428 · Cited by 61
“Although mutations in SQSTM1 have originally been identified in patients with Paget disease of bone (PDB) [107], a recent study has revealed several missense variants in SQSTM1 in familial as well as sporadic ALS [64].”
BackgroundRea, S. L., Walsh, J. P., Ward, L., Magno, A. L., Ward, B. K., Shaw, B., Layfield, R., Kent, G. N., Xu, J., & Ratajczak, T. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090214 · Cited by 60
“The reported prevalence of SQSTM1 mutations ranges widely from 0% to 16% in sporadic patients((3,4)) and 18% to 46% in familial patients.”
BackgroundMechanical stress meets autophagy: potential implications for physiology and pathology
King, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.08.002 · Cited by 66
SQSTM1 mutations in Han Chinese populations with sporadic amyotrophic lateral sclerosis
Chen, Y., Zheng, Z., Chen, X., Huang, R., Yang, Y., Yuan, L., Pan, L., Hadano, S., & Shang, H. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.008 · Cited by 66
Hadano, S., Mitsui, S., Pan, L., Otomo, A., Kubo, M., Sato, K., Ono, S., Onodera, W., Abe, K., Chen, X.-P., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw180 · Cited by 62
“SQSTM1 mutations have originally been identified in patients with Paget disease of bone (PDB) (27), and its gene product, SQSTM1, is known to regulate not only the selective-autophagy via association with LC3 and ubiquitinated misfolded proteins (28,29), but also the kelch-like ECH-associated protein 1 (KEAP1)-nuclear…”
BackgroundEpidemiology and pathology of Paget’s disease of bone – a review
Nebot, E., & Pietschmann, P. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0496-4 · Cited by 61
Beyens, G., Daroszewska, A., de Freitas, F., Fransen, E., Vanhoenacker, F., Verbruggen, L., Zmierczak, H.-G., Westhovens, R., Van Offel, J., Ralston, S. H., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070333 · Cited by 59
“However, thus far, only one PDB-causing gene has been identified: the SQSTM1 gene, which is located in the PDB3 region on chromosome 5q35.((26,27)) The SQSTM1/ p62 protein is a scaffold protein in the RANK signaling cascade,((28,29)) but the exact pathogenic mechanism of the PDB mutations remains to be elucidated.”
BackgroundBone and the Innate Immune System
Charles, J. F., & Nakamura, M. C. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0195-2 · Cited by 58
Cundy, T., & Bolland, M. J. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.06.001 · Cited by 65
Implications of Selective Autophagy Dysfunction for ALS Pathology
Vicencio, E., Beltrán, S., Labrador, L., Manque, P., Nassif, M., & Woehlbier, U. (2020) · Cells · doi:10.3390/cells9020381 · Cited by 66
Biology and Treatment of Paget's Disease of Bone
Vallet, M., & Ralston, S. H. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25291 · Cited by 66
“A recurrent mutation resulting in a Proline to Leucine amino acid change at codon 392 (P392L) was first identified in the French-Canadian population [Laurin et al., 2002] and soon after this other mutations in SQSTM1were identified in the UK population [Hocking et al.”
BackgroundPhase Separation in Regulation of Aggrephagy
Sun, D., Wu, R., Li, P., & Yu, L. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.06.026 · Cited by 55
Albagha, O., Visconti, M. R., Alonso, N., Wani, S., Goodman, K., Fraser, W. D., Gennari, L., Merlotti, D., Gianfrancesco, F., Esposito, T., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1975 · Cited by 64
“The single most important susceptibility gene is SQSTM1, which harbors mutations in up to 40% of patients with a family history of PDB and in 5% to 10% of patients with no family history.((4,5))”
BackgroundChung, P. Y. J., Beyens, G., Boonen, S., Papapoulos, S. E., Geusens, P., Karperien, M., Vanhoenacker, F. M. H. M., Verbruggen, L., Fransén, E., Offel, J. V., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0888-2 · Cited by 63
“3% of PDB families showing mutations in this gene (Beyens et al. 2006; Chung et al. 2008; Collet et al. 2007; Eekhoff et al. 2004; Falchetti et al. 2005; Falchetti et al. 2004; Falchetti et al. 2009; Gennari et al. 2006; Good et al. 2004; Hocking et al. 2004; JohnsonPais et al. 2003; Laurin et al. 2002; Lucas et al. 2…”
BackgroundPaget's disease of bone: clinical review and update
Bolland, M. J., & Cundy, T. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201688 · Cited by 63
Etiology of Paget's disease and osteoclast abnormalities
Reddy, S. V. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20256 · Cited by 57
“More recently, the gene encoding sequestosome 1 (SQSTM1/p62) mapped within the critical region on chromosome 5q35-qter identified a proline-leucine amino acid change at codon392 (P392L) inFrench-Canadianpatients withPaget’s disease of bone [Laurin et al., 2002].”
BackgroundAutosomal Dominant Inclusion Body Myopathy, Paget Disease of Bone, and Frontotemporal Dementia
Kimonis, V. E., & Watts, G. D. J. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000183081.76820.5a · Cited by 56
“8 The gene for the 5q35 locus in French-Canadian families was identified as the ubiquitin binding protein, Sequestosome 1 (SQSTM1; p62), mutations of which have been associated with sporadically occurring PDB. 9,10 Frontotemporal dementia causes a substantial proportion of cases of primary degenerative dementia occurri…”
BackgroundInfluentialGuerreiro, R., Bras, J., Hardy, J., & Singleton, A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu203 · Cited by 55
Genetics of Paget’s Disease of Bone
Ralston, S. H., & Albagha, O. (2012) · Elsevier eBooks · doi:10.1007/s11914-014-0219-y · Cited by 61
“For example, loss of function mutations have been reported in TNFRSF11B gene causing juvenile PDB, a rare early-onset form of PDB.18,19 Certain missense mutations in the VCP gene cause Inclusion Body Myopathy Paget’s disease and frontotemporal dementia,20 and mutations in hnRNPA2B1and hnRNPA1 were recently reported to…”
BackgroundInfluentialRANKL/RANK as Key Factors for Osteoclast Development and Bone Loss in Arthropathies
Leibbrandt, A., & Penninger, J. M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0298-6_7 · Cited by 59
Merchant, A., Smielewska, M., Patel, N., Akunowicz, J. D., Saria, E. A., Delaney, J. D., Leach, R. J., Seton, M., & Hansen, M. F. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081105 · Cited by 54
“In all but one case,((24)) the constitutional mutations were found in the heterozygous state.”
BackgroundIs the Prevalence of Paget's Disease of Bone Decreasing?
Cundy, T. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s202 · Cited by 60
Walsh, J. P. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06265.x · Cited by 61
Evaluation of the Role of the SQSTM1 Gene in Sporadic Belgian Patients with Paget’s Disease
Beyens, G., Hul, E. V., Driessche, K. V., Fransén, E., Devogelaer, J. P., Vanhoenacker, F. M. H. M., Offel, J. V., Verbruggen, L., Clerck, L. S. D., Westhovens, R., et al. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0244-4 · Cited by 59
“(Table 1), and the P392L mutation turned out to be recurrent [18, 29, 30].”
InfluentialHeritable disorders of the RANKL/OPG/RANK signaling pathway.
Whyte, M. P., & Mumm, S. R. (2004) · PubMed · Cited by 58
Update on the pathogenesis and genetics of Paget’s disease of bone
Gennari, L., Rendina, D., Merlotti, D., Cavati, G., Mingiano, C., Cosso, R., Materozzi, M., Pirrotta, F., Abate, V., Calabrese, M., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.932065 · Cited by 60
“Following the two positional cloning studies in 2002 (Hocking et al., 2002; Laurin et al., 2002), at least 30 different mutations is SQSTM1 have been associated with PDB.”
BackgroundIshii, T., Warabi, E., Siow, R. C. M., & Mann, G. E. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.019 · Cited by 56
“Analyses of the SQSTM1 human gene, which locates at 5q35-qter, revealed it is the locus for type 3 familial PDB [36,37].”
InfluentialRare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis
Gang, Q., Bettencourt, C., Machado, P. M., Brady, S., Holton, J. L., Pittman, A. M., Hughes, D., Healy, E., Parton, M., Hilton-Jones, D., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.024 · Cited by 51
“P392L located in the C-terminal ubiquitin-associated domain, where most mutations lie in, is the most frequent SQSTM1 mutation in all the different clinical phenotypes (Fecto et al., 2011; Laurin et al., 2002).”
BackgroundInfluentialLucas, G., Hocking, L. J., Daroszewska, A., Cundy, T., Nicholson, G. C., Walsh, J. P., Fraser, W. D., Meier, C., Hooper, M. J., & Ralston, S. H. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041106 · Cited by 55
“(13) Patients were classified as having “sporadic” PDB if they did not have a positive family history of the disease and familial PDB if they knew of at least one other blood relative who had been diagnosed with PDB.”
BackgroundInfluentialPathophysiological Role of Autophagy: Lesson from Autophagy-Deficient Mouse Models
Ichimura, Y., & Komatsu, M. (2011) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.60.329 · Cited by 54
“The p62 protein is a ubiquitously expressed cellular protein that is conserved in metazoa but not in plants and fungi, and it has been known that the mutations give rise to inherited Paget’s disease [17, 48].”
BackgroundNajat, D., Garner, T., Hagen, T., Shaw, B., Sheppard, P. W., Falchetti, A., Marini, F., Brandi, M. L., Long, J. E., Cavey, J. R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081204 · Cited by 50
Paget's disease of bone--becoming a rarity?
Bastin, S., Bird, H., Gamble, G., & Cundy, T. (2009) · Rheumatology · doi:10.1093/rheumatology/kep212 · Cited by 52
Contribution of Genetic Factors to the Pathogenesis of Paget's Disease of Bone and Related Disorders
Lucas, G., Daroszewska, A., & Ralston, S. H. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s206 · Cited by 53
“(47,48) This work and other reports of nonlinkage of PDB to chromosome 18q21(49,50) have led to the general conclusion that mutations in the RANK gene are not a common cause of classical, late-onset PDB.”
BackgroundInfluentialInvolvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis
Lee, J., Tan, V. X., Lovejoy, D. B., Braidy, N., Rowe, D. B., Brew, B. J., & Guillemin, G. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.011 · Cited by 52
Iyama, K., Matsuse, M., Mitsutake, N., Rogounovitch, T., Saenko, V., Suzuki, K., Ashizawa, M., Ookouchi, C., Suzuki, S., Mizunuma, H., et al. (2017) · Thyroid · doi:10.1089/thy.2016.0673 · Cited by 49
“Note that mutations in the C-terminus of SQSTM1 have been reported to cause Paget’s bone disease (28).”
Emerging understanding of the genotype–phenotype relationship in amyotrophic lateral sclerosis
Goutman, S. A., Chen, K. S., Paez-Colasante, X., & Feldman, E. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00039-9 · Cited by 53
Gentile, F., Scarlino, S., Falzone, Y., Lunetta, C., Tremolizzo, L., Quattrini, A., & Riva, N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00601 · Cited by 52
Genetics of Paget’s disease of bone
Michou, L., Collet, C., Laplanche, J., Orcel, P., & Cornélis, F. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2005.05.009 · Cited by 55
Lucas, G., Riches, P. L., Hocking, L. J., Cundy, T., Nicholson, G. C., Walsh, J. P., & Ralston, S. H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071004 · Cited by 52
“Mutations affecting the ubiquitin associated (UBA) of SQSTM1 were subsequently found to account for 5q35-linked PDB in both populations,((22,23)) and SQSTM1 mutations have now been identified as an important cause of PDB by a wide variety of investigators in several populations.”
BackgroundInfluential
Metadata
- Authors
- Laurin, N., Brown, J. P., Morissette, J., & Raymond, V.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Raymond, Vincent
- ORCID
- Brown, Jacques P.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 70
- Issue
- 6
- Pages
- 1582-1588
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC379146
- OpenAlex
- W2011308707
- Cited by
- 563
- References
- 47
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 10 · 2023: 23 · 2022: 14 · 2021: 19 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 14 · 2016: 34 · 2015: 28 · 2014: 35 · 2013: 30 · 2012: 31
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4066 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds pour la Formation de Chercheurs et l'Aide à la Recherche
- Canadian Institutes of Health Research (MOP-3804)
- Fonds de Recherche du Québec - Santé
- Canada Foundation for Innovation (548)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Keywords
- Paget's disease of bone, p62, recurrent mutations, ubiquitin-associated domain, haplotype mapping, French-Canadian families, NF-κB signaling, genetic susceptibility, bone turnover
- MeSH terms
- Sequestosome-1 Protein, Base Sequence, Canada, Carrier Proteins, France, Genetic Testing, Haplotypes, Heterozygote, Homozygote, Humans, Molecular Sequence Data, Mutation, Osteitis Deformans, Proteins, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.